1987
DOI: 10.1002/j.1460-2075.1987.tb02416.x
|View full text |Cite
|
Sign up to set email alerts
|

Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (beta 2-microglobulin) chains of HLA class I antigens.

Abstract: In man a number of diseases are associated with certain alleles of MHC antigens. The most pronounced example is ankylosing spondylitis, which is strongly associated with HLA‐B27. As a first step towards a model system to study the basis of this association, transgenic mice were generated that showed cell surface expression of the HLA‐B27 antigen biochemically indistinguishable from HLA‐B27 antigen expressed on human cells. This result was obtained by crossing two independently derived strains of mice, one of w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
28
2

Year Published

1989
1989
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 80 publications
(30 citation statements)
references
References 18 publications
0
28
2
Order By: Relevance
“…In our B27 transgenic mouse model as well as in transgenic mouse models described by other investigators (26,(52)(53)(54)(55)(56), but unlike the findings in the B27 transgenic rat model (4)(5)(6), the transgenic mouse model studied by Weinreich et a1 (57), or the recently described model of HLA-B27 transgenic mice lacking P2m (58), no spontaneous or induced manifestation of disease occurs. It nevertheless provides a model suitable for defining a bacteria-specific CD8 immune response.…”
Section: Discussioncontrasting
confidence: 42%
See 1 more Smart Citation
“…In our B27 transgenic mouse model as well as in transgenic mouse models described by other investigators (26,(52)(53)(54)(55)(56), but unlike the findings in the B27 transgenic rat model (4)(5)(6), the transgenic mouse model studied by Weinreich et a1 (57), or the recently described model of HLA-B27 transgenic mice lacking P2m (58), no spontaneous or induced manifestation of disease occurs. It nevertheless provides a model suitable for defining a bacteria-specific CD8 immune response.…”
Section: Discussioncontrasting
confidence: 42%
“…A 25-kb Sal I fragment of this clone containing the B*2705 gene was then used to establish the B*2705 transgenic mouse line. Founder mice containing 1 copy of the B*2705 gene were backcrossed to a human p,m-expressing transgenic mouse line (26). The double transgene B*2705hpzm was backcrossed onto CBA mice, and a stable double-transgenic mouse line established (21).…”
Section: Materials An11 Methodsmentioning
confidence: 99%
“…To obtain efficient expression at the cell surface of human class I molecules in transgenic mice, the simultaneous presence of the class I transgene and a human 132-microglobulin (h132m) transgene is required (Krimpenfort et al, 1987). We have described animals in which the HLA-B27 and h[32m gene were introduced on a single DNA fragment and where, consequently, these transgenes cosegregate (Baas, 1993).…”
mentioning
confidence: 99%
“…The ANKENT and SIA models have been described using different B27 transgenes (B*2702 and B*2705, respectively (Krimpenfort et al 1987;Nickerson et al 1990), as well as independently produced ko founders (Zijlstra et al 1989;Koller and Smithies 1989, respectively). Moreover, ANKENT and SIA have distinct pathological characteristics: nail changes, synovial inflammation, and phalangeal joint involvement are present in SIA (Khare et al 1995) but absent in ANKENT (Weinreich et al 1995a).…”
Section: H2 Class I Epitopes In Hu-b2m-reconstituted Ko Micementioning
confidence: 99%
“…The establishment of β2m knockouts by homologous recombination (Zijlstra et al 1989) and doubly transgenic HLA-B*2702, hu-β2m mice has been described previously (Krimpenfort et al 1987). Mice were housed under conventional conditions.…”
mentioning
confidence: 99%